Magnetic Resonance Imaging + Laboratory Biomarker Analysis + Radiation Therapy + Vincristine + Lomustine + Cyclophosphamide + CISPLATIN + Vincristine Sulfate for medulloblastoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 31 Mar 2016: Trial registered, NCT02724579
  2. 17 Nov 2017: Trial started, NCT02724579

The trials

NCT02724579: Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma

State
Under way
Phase
Phase 2
People
45 planned
Started
17 Nov 2017
Primary completion
31 Mar 2028
Arms
Treatment (reduced radiation therapy and chemotherapy)
Results
None posted
  1. 31 Mar 2016: Trial registered
  2. 17 Nov 2017: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.